首页> 美国卫生研究院文献>Oncology Letters >Evaluation of the clinical characteristics management and prognosis of 103 patients with gastric mucosa-associated lymphoid tissue lymphoma
【2h】

Evaluation of the clinical characteristics management and prognosis of 103 patients with gastric mucosa-associated lymphoid tissue lymphoma

机译:胃黏膜相关淋巴样组织淋巴瘤103例临床特征治疗及预后评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The diagnosis of gastric mucosa-associated lymphoid tissue (MALT) lymphoma is difficult owing to its non-specific symptoms and various endoscopic findings. Treatments such as radiotherapy (RT) for localized and chemotherapy (CT) for advanced stages of the disease are employed. The aim of the present study was to examine the clinical characteristics and prognostic factors of Helicobacter pylori (H. pylori) eradication (HPE) in patients with gastric MALT lymphoma. The medical records of 103 patients with gastric MALT lymphoma for the period 2001–2013, were analyzed. The 103 median age of the patients was 53 years and the male to female ratio was 1:1. Serum lactate dehydrogenase and β2-microglobulin were within normal range. Macroscopically, the most commonly involved site was the antrum, followed by the corpus and fundus. A total of 97 patients (94%) tested positive for H. pylori. Forty patients (39%) had stage I, 35 patients (35%) had local or distant nodal involvement, 20 of 103 patients had stage IIIE (19%) and 8 of 103 patients had stage IV (7%) disease. Complete remission, after HPE, was achieved in 54 of the 69 patients (78%) that were H. pylori-positive and in 2 of the 4 patients (50%) that were H. pylori-negative. HPE had a superior trend in the H. pylori-positive patients although no significant difference was identified in the two groups (p=0.194). In patients with advanced disease, the 5-year progression-free survival (PFS) and overall survival (OS) estimates were significantly improoved for patients receiving HPE with CT or RT than those receiving CT or RT (p=0.046 and 0.035, respectively). The multivariate analysis revealed that, the advanced stages were independently associated with shorter PFS, and the modified-International Prognostic Index (m-IPI) (≥2) was associated with shorter OS. In conclusion, gastric MALT lymphoma had a favorable outcome with a high OS rate. HPE was an effective treatment for gastric MALT lymphoma. The patients with advanced stages and m-IPI (≥2) had a much worse prognosis.
机译:胃黏膜相关淋巴样组织(MALT)淋巴瘤由于其非特异性症状和各种内窥镜检查结果而难以诊断。采用诸如局部放疗(RT)和晚期疾病化疗(CT)的治疗方法。本研究的目的是检查胃MALT淋巴瘤患者的幽门螺杆菌(H. pylori)根除(HPE)的临床特征和预后因素。分析了2001年至2013年间103例胃MALT淋巴瘤患者的病历。患者的103位中位年龄为53岁,男女之比为1:1。血清乳酸脱氢酶和β2-微球蛋白在正常范围内。宏观上,最常见的部位是胃窦,其次是the体和眼底。共有97位患者(94%)的幽门螺杆菌检测为阳性。 40例(39%)处于I期,35例(35%)有局部或远处淋巴结受累,103例患者中有20例为IIIE期(19%),103例患者中有8例为IV期(7%)。 HPE后,在69例幽门螺杆菌阳性患者中有54例(78%)达到完全缓解,在4例幽门螺杆菌阴性患者中有2例(50%)达到了完全缓解。 HPE在幽门螺杆菌阳性患者中有较好的趋势,尽管在两组中未发现显着差异(p = 0.194)。在患有晚期疾病的患者中,接受CT或RT的HPE患者比接受CT或RT的患者的5年无进展生存期(PFS)和总体生存期(OS)估计值显着提高(分别为p = 0.046和0.035) 。多因素分析显示,晚期与独立的PFS短相关,而改良的国际预后指数(m-IPI)(≥2)与短OS相关。总之,胃MALT淋巴瘤的预后良好,OS率高。 HPE是治疗胃MALT淋巴瘤的有效方法。晚期且m-IPI(≥2)的患者预后较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号